Highlights on Fluorine-containing Drugs Approved by U.S. FDA in 2023.
Curr Top Med Chem
; 24(10): 843-849, 2024.
Article
em En
| MEDLINE
| ID: mdl-38445700
ABSTRACT
Fluorine continues to show its potential applications in drug discovery and development, as reflected by twelve drugs being fluorinated out of the fifty-five approved by the FDA in 2023. This concise review highlights the discovery of each of these fluorine-containing drugs in the past year, including its brand name, date of approval, composition, sponsors, indication, and mechanism of action. The relevant future trend is also briefly discussed.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
United States Food and Drug Administration
/
Aprovação de Drogas
/
Flúor
Limite:
Humans
País/Região como assunto:
America do norte
Idioma:
En
Revista:
Curr Top Med Chem
Assunto da revista:
QUIMICA
Ano de publicação:
2024
Tipo de documento:
Article
País de afiliação:
Estados Unidos